During his time as a Blavatnik Fellow, Ying Kai Chan co-founded Cirrus Therapeutics, a company developing first-in-class and best-in-classs ocular medicines, which just recently celebrated an $11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback